
Alzheimer's Drug Discovery Foundation
North America, New York, United States, New York
Description
Provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide.
Investor Profile
Alzheimer's Drug Discovery Foundation has made 47 investments, with 8 in the past 12 months and 70% as lead.
Stage Focus
- Grant (55%)
- Series A (17%)
- Series B (11%)
- Series Unknown (11%)
- Undisclosed (2%)
- Post Ipo Equity (2%)
- Seed (2%)
Country Focus
- United States (70%)
- Spain (11%)
- Canada (9%)
- Switzerland (2%)
- United Kingdom (2%)
- The Netherlands (2%)
- Denmark (2%)
- Sweden (2%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Health Diagnostics
- Pharmaceutical
- Life Science
- Medical Device
- Biopharma
- Neuroscience
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.